BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, April 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 8, 1998
View Archived Issues
Novel actions of statins reported at the 20th Congress of the European Society of Cardiology
Read More
UC-781: stability in gel formulation, anti-HIV activity
Read More
CP-154526, a CRF1 receptor antagonist, reduces stress-induced relapse of drug use in rats
Read More
Ribozyme: Q2 1998 highlights
Read More
Aviron: Q2 and HY fiscal 1998 highlights
Read More
CytRx: Q2 1998 highlights
Read More
Texas Biotechnology: Q2 1998 highlights
Read More
Purlytin enters development for prostate cancer; another cancer indication abandoned
Read More
Licensing and/or CRADA opportunity: drug and method to prevent and treat graft-vs.-host disease
Read More
Licensing opportunity from NIH: method of inducing increased resistance to stroke
Read More
Potent factor Xa inhibitors from RPR for thromboembolic disorders
Read More
Schering AG describes new progestogenic steroids
Read More
Nymox discovers new treatment for E. coli 0157:H7 infection
Read More
New antibacterial/antitumor agents produced by fungal strains discovered by Kyowa Hakko
Read More
Millennium reports advances in the diagnosis, treatment of type II diabetes
Read More
Lilly research leads to dual tachykinin antagonists/5-HT agonists
Read More
Hoechst increases shareholding in Korean joint venture
Read More
Ligand reveals tissue-selective, orally active progestational compound
Read More
Broad-spectrum antiviral agents in development at Pfizer
Read More
Canadian academic researchers identify estrone sulfatase inhibitors
Read More
Gilead announces new clinical trials with GS-1278
Read More
Biora: Q2 1998 highlights
Read More
Novel lipid-lowering agent presented by Wayne Hughes Institute at scientific forum
Read More
Lilly's mGlu agonists exert neuroprotective effects in vivo
Read More
Schwarz to market rectal morphine product developed by Core
Read More
Pfizer selects GH secretagogue as development candidate
Read More
UroCor introduces urine test to identify aggressive bladder cancers
Read More
